Simon A B, Zloto A E
Pacing Clin Electrophysiol. 1979 May;2(3):305-14. doi: 10.1111/j.1540-8159.1979.tb03650.x.
Fifty-nine patients between the ages of 13 and 88 with sinus node disease, who received a permanent ventricular pacemaker between 1965 and 1976 at one institution, were followed to determine the natural history of the disorder after permanent pacing. Nineteen had ischemic heart disease, six had primary myocardial disease, and eight valvular heart disease. In 26, no etiology for the arrhythmia was apparent. The one- and five-year survival was 85.5% and 73.1%, respectively. Patients with underlying heart disease had a significantly poorer survival when compared to those without (58% versus 94% at 36 months) and all but 3 of 13 deaths in the first 36 months were in those with ischemic heart disease. There was a distinct trend toward poor survival in those with heart failure prior to pacemaker implant and those over age 65. Patients with sinus bradycardia alone did best (91% survival three years after implant), while those with bradycardia-tachycardia syndrome and those with sinoatrial arrest alone did distinctly worse (76% and 65% survival at three years, respectively). Twelve of 18 deaths were due to progression of underlying heart disease. The long-term prognosis with symptomatic sinus node disease can be predicted in part by (1) etiology of the underlying heart disease, (2) pre-implant arrhythmia, and (3) ventricular function prior to implant.
1965年至1976年间,一家机构为59例年龄在13岁至88岁之间患有窦房结疾病的患者植入了永久性心室起搏器,并对其进行随访,以确定永久性起搏后该疾病的自然病程。其中19例患有缺血性心脏病,6例患有原发性心肌病,8例患有瓣膜性心脏病。26例患者心律失常的病因不明显。1年和5年生存率分别为85.5%和73.1%。与无基础心脏病的患者相比,有基础心脏病的患者生存率明显更低(36个月时分别为58%和94%),并且在最初36个月内13例死亡患者中除3例之外均患有缺血性心脏病。起搏器植入前有心力衰竭的患者以及年龄超过65岁的患者存在明显的生存不良趋势。仅患有窦性心动过缓的患者预后最佳(植入后三年生存率为91%),而患有心动过缓 - 心动过速综合征的患者和仅患有窦性停搏的患者预后明显更差(三年生存率分别为76%和65%)。18例死亡中有12例是由于基础心脏病的进展。有症状的窦房结疾病的长期预后部分可通过以下因素预测:(1)基础心脏病的病因,(2)植入前的心律失常,以及(3)植入前的心室功能。